Identification of New Urinary Metabolites of Byakangelicin, a Component of Angelicae dahuricae Radix, in Rats |
Kwon, Oh-Seung
(Toxicology Lab., Bioanalysis and Biotransformation Research Center, Korea Institute of Science and Technology)
Song, Yun-Seon (Toxicology Lab., Bioanalysis and Biotransformation Research Center, Korea Institute of Science and Technology) Shin, Kuk-Hyun (Natural Products Research Institute, Seoul National University) Ryu, Jae-Chun (Toxicology Lab., Bioanalysis and Biotransformation Research Center, Korea Institute of Science and Technology) |
1 | Kim, Y. B., Oh, Y. H., Park, I. Y., and Shin, K. H., Crystal structure of byakangelicin. Arch. Pharm. Res., 25 (3), 275-279 (2002) DOI ScienceOn |
2 | Shin, K. H., Chung, M. S., and Cho, T. S., Effects of furanocoumarins from Angelica dahurica on aldose reductase and galactosemic cataract formation in rats. Arch. Pharm. Res., 17(5), 331-336 (1994) DOI ScienceOn |
3 | Shin, K. H., Kang, S. S., and Chi, H. J., Determination of byakangelicin in Angelicae Radix by high-performance liquid chromatography. Kor. J. Pharmacog., 3, 239-241 (1990) |
4 | Saiki, Y., Morinaga, K., Okegawa, O., Sakai, S., and Amaya, Y., On the coumarins of the roots of Angelica dahurica Benth et Hook. Yakugaku Zasshi., 91(12), 1313-1317 (1971) DOI PUBMED |
5 | Oh, H, Lee, H. S., Kim, T., Chai, K. Y., Chung, H. T., Kwon, T. O., Jun, J. Y., Jeong, O. S., Kim, Y. C., and Yun, Y. G., Furonocoumarins from Angelica dahurica with hepatoprotective activity on tacrine-induced cytotoxicity in Hep G2 cells. Planta Med., 68(5), 463-464 (2002) DOI ScienceOn |
6 | Kimura, Y., Ohminami, H., Arichi, H., Okuda, H., Baba, K., Kozawa, M., and Arichi, S., Effects of various coumarins from roots of Angelica dahurica on actions of adrenalin, ACTH and insulin in fat cells. Planta Med., 45, 183-187 (1982) DOI ScienceOn |
7 | Beyer-Mears, A. and Cruz, E., Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes, 34 (1), 15-21 (1985) DOI ScienceOn |
8 | Beyer-Mears, A., Mistry, K., Diecke, F. P., and Cruze, E., Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus. Pharmacology, 52 (5), 292-302 (1996) DOI ScienceOn |
9 | Terashima, H., Hama, K., Yamamoto, R., Tsuboshima, M., Kikkawa, R., Hatanaka, I., and Shigeta, Y., Effects of a new aldose reductase inhibitor on various tissues in vitro. J. Pharmacol. Exp. Ther., 229, 226-230 (1984) PUBMED |
10 | Ao, S., Kikuchi, C., Ono, T., and Notsu, Y., Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract. Invest. Ophthalmol. Vis. Sci., 32 (12), 3078-3083 (1991) |
11 | Tomlinson, D. R., Stevens, E. J., and Diemel, L. T., Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol. Sci., 15, 293-297 (1994) DOI ScienceOn |
12 | Kador, P. F., The role of aldose reductase in the development of diabetic complications. Med. Res. Rev., 8, 325-352 (1988) DOI PUBMED ScienceOn |
13 | Shin, K. H. and Woo, W. S., Inhibition of hepatic microsomal drug-metabolizing enzyme by imperatorin. Arch. Pharm. Res., 9, 81-85 (1986) DOI ScienceOn |